Treatment with noninvasive ventilation and continuous positive airway pressure provided similar improvements in pulmonary hypertension and left ventricular diastolic dysfunction in obesity hypoventilation syndrome and concomitant severe obstructive sleep apnea.
Even after long-term continuous positive airway pressure (CPAP) use, intensive telemedicine support can be used to help optimize CPAP adherence in patients with obstructive sleep apnea.
Increased compliance with continuous positive airway pressure therapy may reduce the risk for the development of diabetic retinopathy in patients with type 2 diabetes who have obstructive sleep apnea.
The severity of obstructive sleep apnea is independently associated with subclinical systemic atherosclerosis, which highlights its potential as a predictive factor for cardiovascular disease.
Patients with sleep apnea are 4 more likely to be prescribed home oxygen after hospital discharge than those without sleep apnea.
Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.
Obstructive sleep apnea increases left ventricular hypertrophy in patients with treatment-resistant hypertension.
Obstructive sleep apnea increases the risk for chronic kidney disease in patients who have recovered from an episode of acute cardiogenic pulmonary edema.
The interaction between obstructive sleep apnea and long sleep duration was associated with a nearly 3-fold chance of having a coronary artery calcium score of >100.
A simple, efficient algorithm has been developed that will help to classify symptom subtypes among patients with obstructive sleep apnea based on only 6 symptom items.
